πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 3,494 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 10588897

Piericidin bacterial inhibitors

The Regents of the University of California Β· Granted Tue Mar 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10588982

Site-specific covalent chemical ligation to monoclonal and polyclonal immunoglobulin

The Regents of the University of California Β· Granted Tue Mar 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10588867

Modulating antibacterial immunity via bacterial membrane-coated nanoparticles

The Regents of the University of California Β· Granted Tue Mar 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10589250

Automated purification and formulation device for radiopharmaceutical compounds

The Regents of the University of California Β· Granted Tue Mar 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10590182

Binding-triggered transcriptional switches and methods of use thereof

The Regents of the University of California Β· Granted Tue Mar 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10591471

Suppression of SPLA2-integrin binding for treating an inflammatory condition or suppressin

The Regents of the University of California Β· Granted Tue Mar 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10584105

Immunoproteasome inhibitor analogs

The Regents of the University of California Β· Granted Tue Mar 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10583180

Method for treating adenosine deaminase severe combined imunodeficiency

The Regents of the University of California Β· Granted Tue Mar 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10576079

Multi-drug therapies for tuberculosis treatment

The Regents of the University of California Β· Granted Tue Mar 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10578608

Tools to detect, track and target cancer cells in vivo

The Regents of the University of California Β· Granted Tue Mar 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10577631

Methods and compositions for RNA-directed target DNA modification and for RNA-directed mod

The Regents of the University of California Β· Granted Tue Mar 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10570418

Methods and compositions for RNA-directed target DNA modification

The Regents of the University of California Β· Granted Tue Feb 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10570419

Methods and compositions for RNA-directed target DNA modification and for RNA-directed mod

The Regents of the University of California Β· Granted Tue Feb 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10570124

Deoxycytidine kinase binding compounds

The Regents of the University of California Β· Granted Tue Feb 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10568844

RNAi molecule delivery platform based on single-siRNA and shRNA nanocapsules

The Regents of the University of California Β· Granted Tue Feb 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10563227

Methods and compositions for RNA-directed target DNA modification and for RNA-directed mod

The Regents of the University of California Β· Granted Tue Feb 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10562839

Medium chain fatty acid esters of Ξ²-hydroxybutyrate and butanediol and compositions and me

The Regents of the University of California Β· Granted Tue Feb 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10562886

Anti-cancer compounds

The Regents of the University of California Β· Granted Tue Feb 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10556021

Nanocarriers for drug delivery

The Regents of the University of California Β· Granted Tue Feb 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10556892

Piperazinyl methanone NAAA inhibitors

The Regents of the University of California Β· Granted Tue Feb 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10550407

Methods and compositions for RNA-directed target DNA modification and for RNA-directed mod

The Regents of the University of California Β· Granted Tue Feb 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10550163

Peptide fragments of netrin-1 and compositions and methods thereof

The Regents of the University of California Β· Granted Tue Feb 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10550195

Tumor selective macropinocytosis-dependent rapidly internalizing antibodies

The Regents of the University of California Β· Granted Tue Feb 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10543221

Beta-lactamase inhibitors, formulations, and uses thereof

The Regents of the University of California Β· Granted Tue Jan 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted